Both previous studies investigating Fra-1 by immunohistochemistry in IDC and DCIS samples found Fra-1-positive staining in all analysed cases, in disagreement with our data.13,14 The reason for such differences is uncertain, but may be attributable to different criteria for positivity and the number of patients studied. Here, FOSL1 is linked to ductal breast carcinoma in situ.